A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 07 Feb 2019
At a glance
- Drugs Abemaciclib (Primary) ; Abiraterone acetate; Prednisone
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 03 Dec 2018 Status changed from not yet recruiting to recruiting.
- 19 Nov 2018 Planned initiation date changed from 17 Oct 2018 to 26 Nov 2018.
- 23 Oct 2018 New trial record